John Leonard
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intellia Therapeutics, Inc. (NTLA) | CEO | $708,000 | $5,063,899 |
| 2024 | Intellia Therapeutics, Inc. (NTLA) | CEO | $687,000 | $15,330,547 |
| 2023 | Intellia Therapeutics, Inc. (NTLA) | CEO | $660,000 | $11,657,262 |
| 2022 | Intellia Therapeutics, Inc. (NTLA) | CEO | $630,000 | $10,096,590 |
| 2021 | Intellia Therapeutics, Inc. (NTLA) | CEO | $600,000 | $9,773,560 |
| 2020 | Intellia Therapeutics, Inc. (NTLA) | CEO | $580,000 | $3,635,676 |
| 2019 | Intellia Therapeutics, Inc. (NTLA) | CEO | $559,200 | $903,786 |
| 2018 | Intellia Therapeutics, Inc. (NTLA) | CEO | $550,000 | $9,708,330 |
| 2017 | Intellia Therapeutics, Inc. (NTLA) | CEO | $395,833 | $2,592,874 |
Earnings-call appearances
-
Intellia Therapeutics Second Quarter 2026 Earnings Conference Call2026-08-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-26
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-07
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-08
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2024 Earnings Call2025-01-10
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-07
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-22
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-09
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-03
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-04
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2021 Earnings Call2022-01-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2020 Earnings Call2021-01-07
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
Intellia Therapeutics, Inc. (NTLA)
-
BIO-TECHNE Corp Q2 FY2020 Earnings Call2020-02-04
BIO-TECHNE Corp (TECH)